

UK TRADING UPDATE SUMMARY: SourceBio Tips Jump In Virus Testing Demand


Destiny Pharma Set For GBP11.5 Million Raise To Buy NTCD-M3


IN BRIEF: Destiny Pharma Set To Complete Study Recruitment By 2020 End


(Sharecast News) - Clinical-stage biotechnology company Destiny Pharma updated the market on its 'XF-73' phase 2b clinical study with 101 patients on ...


IN BRIEF: Destiny Pharma Notes XF-73 Study Recruitment On Track


UK EARNINGS SUMMARY: Novacyt Profit Leaps On Covid-19 Test Kit Demand


IN BRIEF: Destiny Pharma To Co-Develop Covid-19 Prevention Product


(Sharecast News) - Clinical-stage biotechnology company Destiny Pharma has entered into a collaboration agreement with SporeGen, it announced on Monda...